|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Yukon Medical Announces Receipt of Grant Under the 2010 Qualifying Therapeutic Discovery Project (QTDP)
11/17/2010 9:28:35 AM
DURHAM, N.C.--(BUSINESS WIRE)--Yukon Medical, LLC, a medical device firm located in Research Triangle Park, NC, is proud to announce it has received a grant under the 2010 Qualifying Therapeutic Discovery Project (QTDP) for their SmartMix™ delivery platform. The IRS, in conjunction with the Department of Health and Human Services, approved applications for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness. The program was created by the US Patient Protection and Affordable Care Act of 2010 and oversaw the allocation of $1 billion in tax credits and grants for the 2009 and 2010. Assisted by its accounting firm Langdon & Co. of Garner, the grant application submitted by Yukon resulted in an award of $244,479.25 in furtherance of its “development of a safe, effective and efficient method for reconstitution of lyophilized drugs and biologics.”
|
|
|
|
|
|
|
|
|
|
|